Transient hyperglycemia in hispanic children with acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 45, Issue 7, 2005, Pages 960-963

  Baillargeon, Jacques ^a,b   Langevin, Anne Marie ^b,c   Mullins, Judith ^d   Ferry Jr , Robert J ^b   DeAngulo, Guillermo ^d   Thomas, Paul J ^c   Estrada, Jaime ^e   Pitney, Aaron ^f   Pollock, Brad H ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c Santa Rosa Children's Hospital   (United States)

^d DRISCOLL CHILDREN S HOSPITAL   (United States)

^e Methodist Children's Hospital of South Texas   (United States)

^f WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

Acute lymphoblastic leukemia; Children; Glucose; Obesity

Indexed keywords

ASPARAGINASE; DAUNORUBICIN; DEXAMETHASONE; GLUCOCORTICOID; INSULIN; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; ARTICLE; BODY MASS; CANCER CHEMOTHERAPY; CHILDHOOD LEUKEMIA; COHORT ANALYSIS; FEEDING BEHAVIOR; FEMALE; HISPANIC; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; OBESITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; UNITED STATES;

ADOLESCENT; AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HISPANIC AMERICANS; HUMANS; HYPERGLYCEMIA; INCIDENCE; LEUKEMIA, B-CELL, ACUTE; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; OBESITY; RISK FACTORS; SEX FACTORS;

EID: 27644518362     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20320     Document Type: Article

References (21)

1. Howard S, Pui C. Endocrine complications in pediatric patients with acute lymphoblastic leukemia. Blood Rev 2002;16:225-243.
2. Weiser M, Cabanillas M, Konopleva M, et al. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lympocytic leukemia with hyperfractionated cyclophosphamide, vincistine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. Cancer 2004;100:1179-1185.
3. Pui C, Burghen G, Bowman W, et al. Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone. J Pediatr 1981;99:46-50.
4. Popkin B, Udry J. Adolescent obesity increases significantly in second and third generation US immigrants: The national longitudinal study of adolescent health. J Nutr 1998;128:701-706.
5. Lacar E, Soto X, Riley W. Adolescent obesity in a low-income Mexican American district in south Texas. Arch Pediatr Adolesc Med 2000;154:837-840.
6. Ogden C, Flegal K, Carroll M, et al. Prevalence and trends in overweight among US children and adolescents 1999-2000. JAMA 2002;288:1, 728-721, 732.
7. Smith M, Carroll M, Gaynon C, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996;14:4-6.
8. Association AD. Type 2 diabetes in children and adolescents. Pediatrics 2000;105:671-680.
9. Nysom K, Holm K, Michaelsen K, et al. Degree of fatness after treatment for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab 1999;84:4, 591-594, 596.
10. Cole T. Weight-stature indices to measure underweight, overweight, and obesity. New York: Wiley-Liss; 1991.
11. Himes J, Dietz W. Guidelines for overweight in adolescent preventive services: Recommendations from an expert committee. Am J Clin Nutr 1994;59:307-316.
12. Strauss R, Pollack H. Epidemic increase in childhood overweight, 1986-1998. JAMA 2001;286:2, 845-842, 848.
13. Burghen G, Givens J, Kitabchi A. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 1980;50.
14. Cavallo-Perin P, Bruno A, Ozzello A, et al. Comparison of acute and subacute effects of deflazacort and prednisone on glucose in man. Eur J Clin Pharmacol 1984;26:357-362.
15. Khan A, Adachi M, Hill J. Diabetogenic effect of 1-asparaginase. J Clinl Endocrinol Metab 1969;29:1372-1376.
16. Pratt C, Choi S, Holton C. Low-dosage asparaginase treatment of childhood acute lymphocytic leukemia. Am J Dis Child 1971;121:406-409.
17. Amiel S, Caprio S, Sherwin R, et al. Insulin resistance of puberty: A defect restricted to peripheral glucose metablism. J Clin Endocrinol Metab 1991;72:277-282.
18. DeFronzo R, Del Prato S. Insulin resistance and diabetes mellitus. J Diabetes Complications 1996;10:243-245.
19. Amiel S, Sherwin R, Simonson D, et al. Impaired insulin action in puberty: A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 1986;315:215-219.
20. Haffner S, Hazuda H, Mitchell D, et al. Increased incidence of type II diabetes in Mexican Americans. Diabetes Care 1991;14:102-108.
21. Talvensaari K, Lanning M, Tapaninen P, et al. Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab 1996;81:3051-3055.